LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ChowChow Cloud International Holdings, Ltd., (“ChowChow” or the "Company") (NYSE:CHOW) investors of a class action on behalf of investors that bought securities between September 16, 2025 and December 10, 2025, inclusive (the “Class Period”). ChowChow investors have until May 12, 2026 to file a lead plaintiff motion.

LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Boston Scientific Corporation, (“Boston Scientific” or the "Company") (NYSE: BSX) investors off a class action on behalf of investors that bought securities between July 3, 2025 and February 3, 2026, inclusive (the “Class Period”). Boston Scientific investors have until May 4, 2026 to file a lead plaintiff motion.

Gold continues to move with interest rates in the US and beyond. With the current conflict still without a resolution, gold and interest rates will continue to be in a state of flux.

Aurora Cannabis stock has slid 19% YTD as competition and weak consumer cannabis weigh, but strong medical growth and rising margins could shape its next move.

JNJ edges out LLY in a tight pharma showdown, backed by stronger valuation and stock performance despite Lilly's explosive GLP-1-driven growth.

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Although the revenue and EPS for Goldman (GS) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

SAN FRANCISCO, April 10, 2026 (GLOBE NEWSWIRE) -- Coty Inc. (NYSE: COTY) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Coty common stock between November 5, 2025 and February 4, 2026. The lawsuit follows Coty's February 5, 2026 Q2 2026 earnings report, depicting serious operational issues, and the abrupt departure of its CEO (Sue Y.

Crude holds above $90 amid Middle East tensions, lifting prospects for MTDR, SM and BP, as higher prices support oil-weighted output and upstream growth.

ImmunityBio stock jumps 7% as Q1 2026 revenues surge 168% on strong Anktiva uptake, with expanding approvals and pipeline progress boosting momentum.

LOS ANGELES, April 10, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Lakeland Industries, Inc. ("Lakeland" or the "Company") (NASDAQ: LAKE). IF YOU SUFFERED A LOSS ON YOUR LAKELAND INVESTMENTS, CLICK HERE BEFORE APRIL 24, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

LOS ANGELES, April 10, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). IF YOU SUFFERED A LOSS ON YOUR BOSTON SCIENTIFIC INVESTMENTS, CLICK HERE BEFORE MAY 4, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

MIDLAND, Texas, April 10, 2026 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (the “Company” or “Diamondback”) today announced the pricing of its tender offers to purchase for cash (the “Offers”) any and all of its outstanding 4.400% Senior Notes due 2051 (the “2051 Notes”) and 4.250% Senior Notes due 2052 (the “2052 Notes” and, together with the 2051 Notes, the “Notes”). The table below shows the applicable Reference Yield and Consideration (as defined below) for the Notes, calculated as of 2:00 p.m., New York City time, today, April 10, 2026, in accordance with the Offer to Purchase, dated April …

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enviri Corporation's (NYSE: NVRI) Clean Earth to Veolia Environnement SA. Under the terms of the proposed transaction, shareholders of Enviri will receive cash consideration of $14.50 - $16.50 for each share of Enviri that they own. KSF is seeking to determine whether this consideration and the proce.

NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C. , a top complex litigation law firm, is investigating ADMA Biologics (NASDAQ: ADMA) (“ADMA Biologics” or the “Company”) for potential violations of the federal securities laws.

Ford Motor and GE Aerospace are using artificial intelligence to improve efficiency and margins, highlighting why manufacturing companies may be less vulnerable to AI disruption than software firms.